A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma (TCR-MM) Are Treated in Italian Centers for Blood Related Diseases
Clinical trial NCT05742217 · COMPLETED
Trial details
- NCT number
- NCT05742217
- Sponsor
- Pfizer
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-05-26
- Primary completion
- 2026-05-31
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.